Critically Ill: Clinical Trials

16 trials for Critically Ill, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed. 16 Phase 2, 3 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 216Completed 16
Phase 13Completed 3
Phase 32Completed 2

Follow Critically Ill: new trials by email Literature Review of Critically Ill trials Research Report on Critically Ill

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Rapid Pathogen Detection in ICU Patients With Suspected Pneumonia on Antimicrobial Therapy
FA Pneumonia Panel - Pneumonia, Critically Ill
Phase 2CompletedChinese University of Hong Kong402024-06-262026-03-06
Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS
Fludrocortisone Acetate, Standard Therapy - Critically Ill, Septic Shock
Phase 2CompletedThe George Institute1552021-02-112024-01-18
Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation
CVVH with Phoxilium® in the first 48h after randomization, CVVH with Biphozyl® in the first 48h after randomization, CVVH with Phoxilium® in the second 48h after randomization (after previous 48h with Biphozyl®) - Critically Ill, Acute Kidney Injury
Phase 2CompletedMedical University Innsbruck882020-08-012024-03-13
Coated Devices to Decrease Infection in the Intensive Care Unit
Coated devices, Control - Critically Ill
Phase 1 / Phase 2CompletedHospital do Coracao1032019-04-062020-03-09
Intensive Nutrition in Critically Ill Adults
Supplemental parenteral nutrition - Critical Illness, Critically Ill
Phase 2CompletedAustralian and New Zealand Intensive Care Research Centre2402018-10-152024-05-24
The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial
Vitamin C, Thiamine, Hydrocortisone, - Shock, Septic, Critically Ill
Phase 2CompletedAustralian and New Zealand Intensive Care Research Centre2162018-05-022019-10-10
Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury
Calcifediol, Calcitriol, Placebos - Critically Ill, Acute Kidney Injury
Phase 2CompletedDavid Leaf1502017-04-032025-09-29
Promotion of Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in ICU Patients.
E-Motion System, Sham E-Motion System - Critically Ill, Malnutrition
Phase 2CompletedE-Motion Medical Ltd.1582016-02-012019-07-10
Screening Elderly Patients for Weaning
Once daily screening, At least twice daily screening - Critically Ill
Phase 2CompletedUnity Health Toronto1022015-01-012017-10-20
Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study
Lactoferrin, Placebo - Critically Ill
Phase 2CompletedQueen's University2142013-11-012017-02-20
The Effect of Thiamine vs. Placebo on VO2 in Critical Illness
Thiamine - Critically Ill, Respiratory Failure
Phase 2CompletedBeth Israel Deaconess Medical Center662013-10-012017-10-02
TEAM: A Trial of Early Activity and Mobility in ICU
Early mobilisation - Critically Ill
Phase 1 / Phase 2CompletedAustralian and New Zealand Intensive Care Research Centre502013-08-012018-08-22
The Use of Methadone in Newborn Infants
Methadone - Premature Birth of Newborn, Critically Ill
Phase 1 / Phase 2CompletedJohn van den Anker602010-12-012018-07-26
Family Preparation Study For Withdrawal of Mechanical Ventilation From Their Family Member
family preparation for withdrawing life support - Mechanical Ventilation, Critically Ill
Phase 2CompletedUniversity of Wisconsin, Madison202003-10-012015-10-05
N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography
N-acetylcysteine, D5W Placebo - Contrast Induced Nephropathy, Critically Ill
Phase 2 / Phase 3CompletedUnity Health Toronto452002-08-012009-01-27
Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)
Filgrastim - Acute Respiratory Failure, Critically Ill
Phase 2 / Phase 3CompletedHelsinki University Central Hospital591996-01-012012-10-29

Narrower conditions

Critical Illness (16)  ·  Acute Kidney Injury (2)  ·  Sepsis (2)  ·  Shock, Septic (2)  ·  Hyperphagia (1)  ·  Infections (1)  ·  Malnutrition (1)  ·  Pneumonia (1)  ·  Pneumonia, Ventilator-Associated (1)  ·  Premature Birth (1)  ·  Respiratory Insufficiency (1)  ·  Vasoplegia (1)

Broader conditions

Disease Attributes (16)  ·  Pathologic Processes (16)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Infections (3)  ·  Inflammation (3)  ·  Respiratory Tract Diseases (3)  ·  Systemic Inflammatory Response Syndrome (3)  ·  Urogenital Diseases (3)  ·  Female Urogenital Diseases (2)  ·  Kidney Diseases (2)  ·  Lung Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Renal Insufficiency (2)  ·  Respiratory Tract Infections (2)

Interventions

Thiamine (2)  ·  Acetylcysteine (1)  ·  Ascorbic Acid (1)  ·  Calcifediol (1)  ·  Calcitriol (1)  ·  Filgrastim (1)  ·  Hydrocortisone (1)  ·  Inulin (1)  ·  Lactoferrin (1)  ·  Methadone (1)  ·  Rehabilitation (1)  ·  Standard of Care (1)  ·  fludrocortisone acetate (1)  ·  sinistrin (1)

Sponsors

Australian and New Zealand Intensive Care Research Centre (3)  ·  Unity Health Toronto (2)  ·  Beth Israel Deaconess Medical Center (1)  ·  Chinese University of Hong Kong (1)  ·  David Leaf (1)  ·  E-Motion Medical Ltd. (1)  ·  Helsinki University Central Hospital (1)  ·  Hospital do Coracao (1)  ·  John van den Anker (1)  ·  Medical University Innsbruck (1)  ·  Queen's University (1)  ·  The George Institute (1)  ·  University of Wisconsin, Madison (1)

Countries

Australia (4)  ·  Canada (4)  ·  United States (4)  ·  New Zealand (3)  ·  Brazil (2)  ·  Austria (1)  ·  Finland (1)  ·  Hong Kong (1)

Top investigators

Alexandre Biasi, MD/PhD (1)  ·  Carol L Hodgson, PhD (1)  ·  Claudio M Martin, MD, FRCPC, MSc (1)  ·  Daren K Heyland, MD (1)  ·  David E Leaf, MD, MMSc (1)  ·  Emma Ridley, PhD (1)  ·  James Walsham, MB ChB, MRCP, FCICM. (1)  ·  John G Muscedere, MD (1)  ·  Karen E. A. Burns, MD, FRCPC (1)  ·  Karin T Kirchhoff (1)  ·  Katherine Berg, MD (1)  ·  Kirsi-Maija Kaukonen, MD, PhD (1)  ·  Michael Joannidis, Univ.-Prof., MD (1)  ·  Nora Luethi, MD (1)  ·  Rinaldo Bellomo, Professor (1)

Results publications

PMID 11098963, PMID 15883741, PMID 23363492, PMID 29924393, PMID 30805946, PMID 30920411, PMID 31142242, PMID 31950979, PMID 32526149, PMID 33315720, PMID 35260448, PMID 39235623, PMID 39762887, PMID 40759107, PMID 40924491, PMID 41247497

NIH funding

K23DK106448 (1)